Cost effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer

Forde, Gareth

466
Cost effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

G. K. Forde¹, J. Chang², A. Ziogas² and R. E. Bristow²
¹University of California at Irvine Medical Center, Orange, CA, ²University of California, Irvine, Irvine, CA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

466
Cost effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer

466 Cost effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer

466
Cost effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer